Save 60% Off all remaining inventory with Promo Code: ICE

DEA Reschedules CBD to Schedule V Drug

September 27, 2018

TESTSTSARDSAR

DEA Reschedules CBD to Schedule V Drug by Alex Moersen

Originally reported by Hemp Industry Daily, the U.S. Drug Enforcement Administration (DEA) has elected to remove some forms of cannabidiol from the Schedule I drug classification. According to a report to be published tomorrow, “the Drug Enforcement Administration places certain drug products that have been approved by the Food and Drug Administration (FDA) and which contain cannabidiol (CBD) in schedule V of the Controlled Substances Act (CSA).” This specifically pertains to drugs including finished dosage formulations of CBD with a THC content below 0.1 percent.

This is the first time the DEA has removed any type of cannabis from Schedule I. This comes just three months after the FDA approved Epidiolex, a CBD-based drug used for rare forms of epilepsy. Without the DEA’s decision on Thursday, doctors would not be able to prescribe the medication as Schedule I drugs cannot be prescribed. Now, Epidiolex will be distributed through standard pharmaceutical channels, from a doctor’s prescription to a drug store, rather than through a dispensary or designated marijuana caregiver.

Schedule V drugs are still illegal without prescriptions, but the DEA claims that they have a low potential for abuse. They are generally pain relievers or antidiarrheal and include Lyrica and prescription-strength Robitussin. However, in the case of Epidiolex, patients will still have to wait to see if it will be covered by insurance, as that decision is made by a separate agency, the Centers for Medicare and Medicaid Services. However, the manufacturer of the drug, London-based GW Pharmaceuticals, has said it will charge $32,500 a year for the treatment, which is comparable to other epilepsy medications.

This rescheduling brings a lot of potential to the CBD industry. It’s obviously an exciting development for investors as this opens the door for further growth. From a medical standpoint, this could lead to further research into the medicinal benefits of CBD and its numerous applications. There is still progress to be had, but the rescheduling is a long-awaited step in the right direction. As James Minutello, CEO of Leaf Logix, told Hemp Industry Daily, “We’re one step closer to finally ending prohibition and legitimizing the industry.”

Feature image courtesy of GW Pharmaceuticals

A link to your site, with your site's name and description as anchor text.





Also in Education

Owning Guns is a Constitutional Right, Unless You’re a Cannabis User

September 28, 2022

Take two of the most hot-button, tendentious issues of our time – cannabis use and gun rights – combine them, and now we really have a debate. As the law currently stands, medical cannabis patients are not afforded their 2nd amendment right to bear arms. Technically, all cannabis consumers are banned from buying guns, but only medical […]

The post Owning Guns is a Constitutional Right, Unless You’re a Cannabis User appeared first on Cannadelics.

Continue Reading

Cannabis policy changes in Africa are welcome. But small producers are the losers

September 28, 2022

TESTSTSARDSAR

Cannabis policy changes in Africa are welcome. But small producers are the losers by Clemence Rusenga

Cannabis is a drug crop with a long history in Africa. Alongside coca and opium poppy, it has been subjected to international control for nearly a century. The International Opium Convention of 1925 institutionalised the international control system and extended the scope of control to cannabis. In 1961 a new international convention was adopted to […]

A link to your site, with your site's name and description as anchor text.

Continue Reading

University of Sydney to Offer Free Cannabis Testing

September 27, 2022

TESTSTSARDSAR

University of Sydney to Offer Free Cannabis Testing by Johnny Green

The University of Sydney is launching a fairly robust study in an attempt to, as the university describes it, “investigate cannabis consumption, behaviours, and attitudes among users.” Part of the study involves offering free, anonymous cannabis testing for people that cultivate their own cannabis in the Australian Capital Territory (ACT). Cannabis was decriminalized in 2020 in the […]

A link to your site, with your site's name and description as anchor text.

Continue Reading

Inventory Clearance Sale

Save 60% Off all remaining inventory with Promo Code: ICE